Case File
efta-efta01461475DOJ Data Set 10CorrespondenceEFTA Document EFTA01461475
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01461475
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
Description
Trade Date
Quantity
Last Prices Unit Cost
Market Value
Unrealized G/L
SANGAMO BIOSCIENCES
05/28/2013
50,000.00
$
19.80
$
8.44
$
990,000.00
$
567,786.00
BIOGEN
02/14/2012
2,095.00
$
312.60
$
119.55
$
654,897.00
$
404,442.05
FOUNDATION MEDICINE
01/13/2014
25,000.00
$
36.40
$
27.51
910,000.00
$
222,336.50
GILEAD SCIENCES INC
2/5/14, 3/7/14
8,100.00
$
72.13
$
79.41
$
584,253.00
$
(58,951.00)
ARIAD PHARMACEUTICALS
2/14/12, 1/24/13
16,535.00
$
7.60
$
17.60
$
125,666.00
$ (165,331.40)
Total Biotec $3,264,816.00
$ 970,282.15
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
CONFIDENTIAL
DB-SDNY-0 123547
SDNY_GM_00269731
EFTA01461475
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.